As Biogen (BIIB) Market Valuation Declined, Holder Endurant Capital Management LP Has Lifted Its Position; Celgene (CELG) Stock Declined While Whalerock Point Partners Has Boosted Its Position

February 20, 2018 - By Migdalia James

Endurant Capital Management Lp increased its stake in Biogen Inc (BIIB) by 25.88% based on its latest 2017Q3 regulatory filing with the SEC. Endurant Capital Management Lp bought 8,185 shares as the company’s stock declined 13.45% while stock markets rallied. The institutional investor held 39,817 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $12.47M, up from 31,632 at the end of the previous reported quarter. Endurant Capital Management Lp who had been investing in Biogen Inc for a number of months, seems to be bullish on the $61.94B market cap company. The stock increased 0.32% or $0.92 during the last trading session, reaching $292.79. About 607,598 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 20, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Whalerock Point Partners Llc increased its stake in Celgene Corp (CELG) by 14.37% based on its latest 2017Q3 regulatory filing with the SEC. Whalerock Point Partners Llc bought 2,987 shares as the company’s stock declined 3.49% while stock markets rallied. The institutional investor held 23,780 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $3.47 million, up from 20,793 at the end of the previous reported quarter. Whalerock Point Partners Llc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $71.31 billion market cap company. The stock decreased 0.48% or $0.46 during the last trading session, reaching $94.8. About 1.38 million shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since February 20, 2017 and is uptrending. It has outperformed by 0.30% the S&P500.

Among 33 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 2 Sell and 12 Hold. Therefore 58% are positive. Celgene Corporation had 132 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Friday, November 17 by BMO Capital Markets. On Monday, July 31 the stock rating was upgraded by Argus Research to “Buy”. Piper Jaffray maintained it with “Hold” rating and $104.0 target in Thursday, January 18 report. The rating was maintained by Cowen & Co with “Buy” on Thursday, October 26. On Thursday, July 6 the stock rating was maintained by Oppenheimer with “Buy”. The company was maintained on Tuesday, October 17 by BMO Capital Markets. The firm has “Buy” rating given on Sunday, October 15 by Jefferies. On Friday, October 20 the stock rating was downgraded by Robert W. Baird to “Neutral”. Credit Suisse maintained Celgene Corporation (NASDAQ:CELG) on Monday, January 8 with “Buy” rating. BMO Capital Markets maintained it with “Outperform” rating and $148 target in Friday, October 27 report.

Whalerock Point Partners Llc, which manages about $651.31M and $283.26 million US Long portfolio, decreased its stake in Seattle Genetics Inc (NASDAQ:SGEN) by 12,600 shares to 36,190 shares, valued at $1.97 million in 2017Q3, according to the filing. It also reduced its holding in Enterprise Products Partners L (NYSE:EPD) by 13,978 shares in the quarter, leaving it with 91,452 shares, and cut its stake in Ishares Msci Emerging Markets (EEM).

Investors sentiment decreased to 1.17 in Q3 2017. Its down 0.17, from 1.34 in 2017Q2. It worsened, as 44 investors sold CELG shares while 457 reduced holdings. 133 funds opened positions while 451 raised stakes. 603.99 million shares or 0.25% more from 602.51 million shares in 2017Q2 were reported. Legal General Group Inc Public Ltd Com reported 0.42% of its portfolio in Celgene Corporation (NASDAQ:CELG). The Missouri-based Monetary Mngmt Grp Inc has invested 2.02% in Celgene Corporation (NASDAQ:CELG). First Bancorp owns 26,270 shares or 0.65% of their US portfolio. Amer Fincl Gru holds 25,000 shares. Fishman Jay A Mi has 24,717 shares for 0.73% of their portfolio. 48,779 were reported by Novare Mgmt Llc. Roosevelt Inv Group Incorporated invested in 1,479 shares. Bank & Trust Of Nova Scotia invested 0.12% of its portfolio in Celgene Corporation (NASDAQ:CELG). Wesbanco Natl Bank Inc has 86,523 shares. 2,300 were reported by Anchor Advsrs Ltd Llc. Epoch Investment Ptnrs Inc owns 96,326 shares. Keybank National Association Oh has invested 0.71% in Celgene Corporation (NASDAQ:CELG). Barclays Public Ltd Liability Com accumulated 558,105 shares or 0.08% of the stock. Penn Davis Mcfarland holds 3.06% or 67,840 shares. Rosenblum Silverman Sutton S F Ca invested 3.74% of its portfolio in Celgene Corporation (NASDAQ:CELG).

Since September 5, 2017, it had 1 buy, and 3 sales for $2.54 million activity. Shares for $248,498 were sold by Curran Terrie. Another trade for 9,250 shares valued at $1.29 million was sold by CASEY MICHAEL D. Shares for $299,594 were bought by Alles Mark J.

Endurant Capital Management Lp, which manages about $127.40M and $330.07 million US Long portfolio, decreased its stake in Celgene Corp (NASDAQ:CELG) by 34,900 shares to 16,300 shares, valued at $2.38M in 2017Q3, according to the filing. It also reduced its holding in Thermo Fisher Scientific Inc (NYSE:TMO) by 33,000 shares in the quarter, leaving it with 59,608 shares, and cut its stake in Kite Pharma Inc (NASDAQ:KITE).

Investors sentiment increased to 1.13 in 2017 Q3. Its up 0.25, from 0.88 in 2017Q2. It improved, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Hanson Doremus Invest Mngmt accumulated 525 shares or 0.06% of the stock. Main Street Llc reported 3,544 shares stake. 5,344 are held by Citizens Northern. Bainco International Invsts invested in 0.7% or 18,671 shares. Da Davidson And accumulated 20,029 shares. 849 were reported by Waters Parkerson And Company Ltd Liability. Lsv Asset Mgmt owns 0.25% invested in Biogen Inc. (NASDAQ:BIIB) for 485,734 shares. Fairfield Bush & invested in 0.98% or 10,000 shares. Parkside Natl Bank Tru has 0.18% invested in Biogen Inc. (NASDAQ:BIIB) for 1,440 shares. Levin Cap Strategies Lp accumulated 3,728 shares or 0.02% of the stock. Sandy Spring Comml Bank holds 0% or 164 shares. D E Shaw invested 0.29% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Eulav Asset reported 31,500 shares. Davis R M stated it has 936 shares. Manning And Napier Advsr Ltd Co owns 737,735 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts